Related Experiment Video

Updated: May 4, 2026

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells
05:16

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells

Published on: December 30, 2025

485

MicroRNA-320 inhibits osteosarcoma cells proliferation by directly targeting fatty acid synthase

Chi Cheng1, Zhen-Qiang Chen, Xue-Tao Shi

  • 1Department of Osteology, Feicheng People's Hospital, Tai'an, 271600, Shandong, China.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|January 7, 2014
PubMed

Insights

MicroRNAs (miRNAs) play a role in cancer. This study shows miR-320 is downregulated in osteosarcoma, inhibiting cancer cell growth and tumor progression, suggesting it acts as a tumor suppressor.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small noncoding RNAs implicated in cancer development.
  • Aberrant miRNA expression is observed in various human tumors.
  • Osteosarcoma is a primary bone malignancy with significant mortality.

Purpose of the Study:

  • To investigate the role of miR-320 in osteosarcoma.
  • To determine the effect of miR-320 on osteosarcoma cell proliferation and apoptosis.
  • To elucidate the molecular mechanism of miR-320 in osteosarcoma.

Main Methods:

  • Quantitative real-time PCR to assess miR-320 expression in osteosarcoma tissues.
  • Transfection of miR-320 mimics into osteosarcoma cell lines (U2OS, MG63).
  • In vivo tumor growth assay in nude mice.
  • Western blot analysis to evaluate fatty acid synthase (FASN) expression.

Main Results:

  • miR-320 was significantly downregulated in osteosarcoma tissues compared to normal tissues.
  • Overexpression of miR-320 inhibited osteosarcoma cell proliferation but did not affect apoptosis.
  • miR-320 overexpression suppressed tumor growth in vivo.
  • miR-320 directly targets and negatively regulates the expression of fatty acid synthase (FASN).

Conclusions:

  • miR-320 functions as a tumor suppressor in osteosarcoma.
  • The miR-320/FASN axis is a potential therapeutic target for osteosarcoma treatment.
  • Downregulation of miR-320 contributes to osteosarcoma progression.

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

6.7K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

10.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K